You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pyrazinamide

Showing 1 - 25 of 207
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet

Recruiting
  • Tuberculosis
  • +2 more
  • Observational PK study
  • Kumasi, Ghana
    Kwame Nkrumah University of Science and Technology
Dec 21, 2022

Tuberculous Meningitis Trial in Worldwide (Rifampicin (RIF), Isoniazid (INH), Linezolid (LZD))

Not yet recruiting
  • Tuberculous Meningitis
  • Rifampicin (RIF)
  • +6 more
  • Porto Alegre, Brazil
  • +9 more
Dec 14, 2022

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

Tuberculosis, Pulmonary Trial (Sitafloxacin, SMZ/TMP, Rifampin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Jul 7, 2022

Tuberculosis Trial in Cape Town (Meropenem Injection, Amoxicillin Clavulanate, Pyrazinamide)

Completed
  • Tuberculosis
  • Meropenem Injection
  • +4 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jan 24, 2022

Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

Recruiting
  • Tuberculosis, Pulmonary
  • Linköping, Sweden
    Linköping University Hospital
Aug 19, 2021

Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

Not yet recruiting
  • Tuberculous Meningitis
  • High dose rifampicin (25mg/kg)
  • +8 more
  • Chennai, Tamil Nadu, India
    ICMR- National Institute for Research in Tuberculosis
Jun 15, 2023

Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)

Completed
  • Pulmonary Tuberculosis
  • Cape Town, South Africa
    University of Cape Town Lung Institute
May 18, 2022

Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis Trial in Niamey (6EH³R³Z, 6EHRZ)

Recruiting
  • Multidrug-resistant Tuberculosis
  • +3 more
  • Niamey, Niger
    Damien Foundation
Oct 29, 2021

or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV

Not yet recruiting
  • Tuberculosis
  • Pulmonary
    • Kampala, Uganda
    • +3 more
    Jul 12, 2021

    Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

    Not yet recruiting
    • Pulmonary Tuberculosis
    • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
    • +3 more
    • (no location specified)
    Jul 25, 2023

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

    Recruiting
    • Tuberculosis, Pulmonary
    • +4 more
    • Johannesburg, South Africa
    • +2 more
    Oct 4, 2021

    Pulmonary Tuberculosis, Body Weight Changes, Motor Activity Trial (Rifampicin, Isoniazid, Pyrazinamide)

    Completed
    Has Results
    • Pulmonary Tuberculosis
    • +2 more
    • (no location specified)
    May 23, 2022

    doTBal® in Tuberculosis: Conduction ofIntensive

    Completed
    • Tuberculosis
    • Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol
    • Mexico City, Mexico
      Laboratorio Silanes, S.A. de C.V.
    Jun 1, 2021

    Disseminated Tuberculosis, HIV Trial in Cape Town (Rifampin, Levofloxacin, Rifampicin, Pyrazinamide, Ethambutol and Isoniazid)

    Recruiting
    • Disseminated Tuberculosis
    • HIV
    • Cape Town, Western Cape, South Africa
    • +1 more
    Mar 30, 2022

    Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

    Not yet recruiting
    • Pulmonary Tuberculosis
    • (no location specified)
    Oct 27, 2023

    Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

    Recruiting
    • Tuberculosis
    • +2 more
    • Johannesburg, Gauteng, South Africa
      Tembisa Clinical Research Centre-The Aurum Institute
    Jun 8, 2022

    Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

    Completed
    • Pulmonary Tuberculoses
    • Other Specified Pulmonary Tuberculosis
    • Cape Town, South Africa
    • +1 more
    Aug 9, 2022

    Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • Tuberculosis Infection
    • Denver, Colorado
    • +14 more
    Mar 2, 2023

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

    Completed
    • Tuberculosis, Pulmonary
    • +4 more
    • Rio de Janeiro, Brazil
    • +25 more
    Jun 23, 2022

    Four Months Moxifloxacin Containing Daily Regimen Study Among

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • Chennai, Tamilnadu, India
      National Institute for Research in Tuberculosis
    Sep 29, 2021

    Pulmonary Tuberculosis Trial in Chennai (Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol)

    Completed
    • Pulmonary Tuberculosis
    • Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol
    • Chennai, Tamilnadu, India
      Tuberculosis Research Centre
    Apr 13, 2021

    Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

    Active, not recruiting
    • Tuberculosis
    • +4 more
    • Bedaquiline Oral Tablet
    • +7 more
    • Port Elizabeth, Eastern Cape, South Africa
    • +1 more
    Oct 20, 2022

    MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

    Active, not recruiting
    • MDR-TB
    • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
    • +9 more
    • Addis Ababa, Ethiopia
    • +12 more
    Oct 12, 2022